Multi-Level Targeting of the Phosphatidylinositol-3-Kinase Pathway in Non-Small Cell Lung Cancer Cells

• Christopher R. Zito,

  Affiliation Yale University School of Medicine & Yale Comprehensive Cancer, New Haven, Connecticut, United States of America

  ⨯
• Lucia B. Jilaveanu,

  Affiliation Yale University School of Medicine & Yale Comprehensive Cancer, New Haven, Connecticut, United States of America

  ⨯
• Valsamo Anagnostou,

  Affiliation Yale University School of Medicine & Yale Comprehensive Cancer, New Haven, Connecticut, United States of America

  ⨯
• David Rimm,

  Affiliation Yale University School of Medicine & Yale Comprehensive Cancer, New Haven, Connecticut, United States of America

  ⨯
• Gerold Bepler,

  Affiliation Karmanos Cancer Institute, Detroit, Michigan, United States of America

  ⨯
• Sauveur-Michel Maira,

  Affiliation Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States of America

  ⨯
• Wolfgang Hackl,

  Affiliation Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States of America

  ⨯
• Robert Camp,

  Affiliation Yale University School of Medicine & Yale Comprehensive Cancer, New Haven, Connecticut, United States of America

  ⨯
• Harriet M. Kluger,

  Affiliation Yale University School of Medicine & Yale Comprehensive Cancer, New Haven, Connecticut, United States of America

  ⨯
• Herta H. Chao

  * E-mail: herta.chao@yale.edu

  Affiliations Yale University School of Medicine & Yale Comprehensive Cancer, New Haven, Connecticut, United States of America, Medical Service, VA Connecticut Healthcare System, West Haven, Connecticut, United States of America

  ⨯